山东:医保创新助力医药产业高质量发展
Qi Lu Wan Bao·2026-01-16 15:34

Core Viewpoint - The Shandong provincial government is implementing comprehensive reforms in drug and medical device regulation to promote high-quality development in the pharmaceutical industry, focusing on enhancing collaboration among departments and optimizing processes to support innovation and reduce the burden on patients [1][2][3] Group 1: Policy Implementation - The Shandong Provincial Medical Security Bureau is accelerating the product listing process and improving the medical insurance payment system to support the innovative development of the pharmaceutical industry while reducing the financial burden on patients [1] - A green channel for product listing was established in 2021, reducing the review frequency from once a month to once a week, and simplifying application materials, resulting in 420 pharmaceutical products from local companies being listed through this channel since the start of the 14th Five-Year Plan [1] Group 2: Payment Mechanism Enhancement - During the 14th Five-Year Plan, 49 new drugs were added to the national medical insurance drug list, with ongoing efforts to negotiate for more Shandong innovative drugs to be included [2] - Innovative drugs that are reasonably used in medical institutions can receive separate compensation through special agreements, and a "dual-channel" system will allow patients to purchase these drugs at designated retail pharmacies with the same reimbursement benefits as in medical institutions [2] Group 3: Multi-layered Support System - Shandong has developed a multi-layered medical security system, with all 16 cities launching customized commercial health insurance to cover high medical costs and expenses outside the insurance catalog, effectively supplementing basic medical insurance [3] - A guidance list for customized commercial health insurance has been established, including around 40 special drugs for cancer treatment and over 10 rare disease drugs, with plans to further optimize this list and include more innovative drugs in the compensation scope [3]

山东:医保创新助力医药产业高质量发展 - Reportify